Cement Manufacturers’ Association (CMA) Announces Mr. Parth Jindal as President; Dr. Raghavpat Singhania Named Vice President
The young leadership to steer Industry engagement and policy advocacy for India's…
Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR
Ghent, Belgium, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Builds upon existing granted…
InnoCare Announces Approval of Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
December 17, 2025 20:48 ET | Source: InnoCare Pharma BEIJING, Dec. 17,…
IAAPA Announces Global Partnership with Expression Capital Partners to Support Growth and Investment Across the Attractions Industry
ORLANDO, Fla., Dec. 16, 2025 /PRNewswire/ -- IAAPA, the premier association representing the…
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
Supports Development of Phospholipid Radioconjugate (PRC) CLR-225 for the Treatment of Solid…
JZXN Announces Talks with an AI Trading Firm for Cooperation; Plans to Acquire Approximately $1 Billion in Tokens at a 30% Discount, Which Would Generate Considerable Book Gains Upon Completion, With the Tokens Scheduled to Be Listed on Binance Soon
HANGZHOU, China, Dec. 16, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (Nasdaq: JZXN)…
BREAKWATER ENERGY HOLDINGS S. R.L. ANNOUNCES PRICING OF AN ADDITIONAL $75 MILLION OF ITS 9% SENIOR SECURED NOTES DUE 2030
LUXEMBOURG, Dec. 16, 2025 /PRNewswire/ -- Breakwater Energy Holdings S.à r.l. (the…
Firstsource announces leadership changes to accelerate growth across Healthcare Payer and Provider businesses
MUMBAI, India, Dec. 15, 2025 /PRNewswire/ -- Firstsource Solutions Limited (NSE: FSL)…
Coldwell Banker India Announces Appointment of Value Add Realty as Area Developer for South India
BENGALURU, India, Dec. 15, 2025 /PRNewswire/ -- Coldwell Banker India today announced…
InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial
BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…
